Mayne Pharma | MYX - 普通股股本



金融业
股票价格
AUD
资产
AUD 1.14B
现金及等价物
AUD 110.07M
销售成本
AUD 43.74M
流动资产
AUD 460.59M
流动负债
AUD 313.94M
债务
AUD 38.82M
EBIT
AUD -16.2M
EBITDA
AUD 20.9M
员工
450
EPS每股收益
AUD -0.15
股本和储备
AUD 454.19M
销售毛利
AUD 86.13M
债务利息支出
AUD 1.2M
贷款资金
AUD 2.66M
市值
AUD 272.24M
净收入
AUD -103.68M
营业费用
AUD 103.54M
营业利润
AUD -3.3M
普通股股本
AUD 81.25M
税前利润
AUD -14.7M
销售收入
AUD 212.07M
销售和管理费用
AUD 54.8M
股票
AUD 74.63M
贸易债权人
AUD 30.25M
应收帐款人
AUD 193.22M


普通股股本 更改 日
Ansell USD 142.94M 885.26M 2025-12
Cochlear AUD 65.4M 1.12B 2025-12
CSL USD 482.13M 93.87M 2025-12
Healius AUD 2.6B 100K 2024-12
Integral Diagnostics AUD 335.09M 1.07M 2024-06
Medical Developments International AUD 112.66M 2.35M 2025-12
Nanosonics AUD 303.35M 188.61M 2025-12
Polynovo AUD 690.84M 991 2025-12
Ramsay Health Care AUD 229.93M 29.81K 2025-12
ResMed USD 145.04M 621.52K 2026-03
Sigma Healthcare AUD 11.5B 9.93B 2025-12
Sonic Healthcare AUD 4.15B 467K 2024-12
Telix Pharmaceuticals AUD 338.78M 379K 2025-12